Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 12/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12078981 | 1.00 | DUT (0.44) | DUTFFAR1 | |
| SCHEMBL12630549 | 0.78 | DUT (0.67) | DUT | |
| SCHEMBL12711102 | 0.77 | DUT (0.47) | DUT | |
| SCHEMBL17517854 | 0.76 | DUT (0.47) | DUTFFAR1 | |
| SCHEMBL12711111 | 0.74 | DUT (0.47) | DUTFFAR1 | |
| SCHEMBL20361933 | 0.74 | DUT (0.66) | DUT | |
| SCHEMBL12630548 | 0.74 | DUT (0.66) | DUT | |
| SCHEMBL1409570 | 0.74 | DUT (0.44) | DUT | |
| SCHEMBL17520397 | 0.72 | DUT (0.46) | DUTFFAR1 | |
| SCHEMBL12711128 | 0.72 | DUT (0.45) | DUTFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3673908-B1 | ANTI-TUMOR EFFECT POTENTIATOR | TAIHO PHARMACEUTICAL CO LTD (JP) | 2022-01-12 | — | — | EP | disclosed |
| EP-3673908-A1 | ANTI-TUMOR EFFECT POTENTIATOR | Taiho Pharmaceutical Co., Ltd. (JP) | 2020-07-01 | — | — | EP | disclosed |
| EP-2508185-B1 | ANTI-TUMOR EFFECT POTENTIATOR | TAIHO PHARMACEUTICAL CO LTD (JP) | 2020-03-04 | — | — | EP | disclosed |
| US-8883759-B2 | Anti-tumor effect potentiator | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8883759-B2 | Anti-tumor effect potentiator | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8883759-B2 | Anti-tumor effect potentiator | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| EP-2508185-A1 | ANTI-TUMOR EFFECT POTENTIATOR | Taiho Pharmaceutical Co., Ltd. (JP) | 2012-10-10 | — | — | EP | disclosed |
| EP-2508185-A1 | ANTI-TUMOR EFFECT POTENTIATOR | Taiho Pharmaceutical Co., Ltd. (JP) | 2012-10-10 | — | — | EP | disclosed |
| US-20120225838-A1 | ANTI-TUMOR EFFECT POTENTIATOR | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2012-09-06 | — | — | US | disclosed |
| US-20120225838-A1 | ANTI-TUMOR EFFECT POTENTIATOR | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2012-09-06 | — | — | US | disclosed |
| US-20120225838-A1 | ANTI-TUMOR EFFECT POTENTIATOR | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2012-09-06 | — | — | US | disclosed |
| WO-2011065541-A1 | ANTI-TUMOR EFFECT POTENTIATOR | 大鵬薬品工業株式会社 (JP) | 2011-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120225838-A1 | ANTI-TUMOR EFFECT POTENTIATOR | CCNT1, CCNA1, UPP1 | DUT 305/4885FFAR1 2926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.